Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


1 Antiviral Res
2 J Gen Virol
1 J Infect
2 J Infect Dis
2 Lancet Infect Dis
4 PLoS One
2 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Antiviral Res

  1. LEE N, Wong CK, Chan MCW, Yeung ESL, et al
    Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: A randomized controlled trial.
    Antiviral Res. 2017 May 20. pii: S0166-3542(17)30141.
    PubMed     Text format     Abstract available

    J Gen Virol

    Influenza: a world of discoveries, outbreaks and controversy.
    J Gen Virol. 2017 May 23. doi: 10.1099/jgv.0.000812.
    PubMed     Text format     Abstract available

  3. HARA K, Kashiwagi T, Hamada N, Watanabe H, et al
    Basic amino acids in the N-terminal half of the PB2 subunit of influenza virus RNA polymerase are involved in both transcription and replication.
    J Gen Virol. 2017 May 22. doi: 10.1099/jgv.0.000750.
    PubMed     Text format     Abstract available

    J Infect

  4. JIN Y, Ren H, Teng Y, Hu M, et al
    Novel reassortment of avian influenza A(H7N9) virus with subtype H6N6 and H5N6 viruses circulating in Guangdong Province, China.
    J Infect. 2017 May 20. pii: S0163-4453(17)30140.
    PubMed     Text format    

    J Infect Dis

  5. YU KO, Randolph AG, Agan AA, Yip WK, et al
    Staphylococcus aureus alpha-toxin Response Distinguishes Respiratory Virus-MRSA Co-infection in Children.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available

  6. RANDOLPH AG, Yip WK, Allen EK, Rosenberger CM, et al
    Evaluation of IFITM3 rs12252 Association with Severe Pediatric Influenza Infection.
    J Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Text format     Abstract available

    Lancet Infect Dis

    Stopping emerging influenza viruses at their origin.
    Lancet Infect Dis. 2017 May 19. pii: S1473-3099(17)30297.
    PubMed     Text format    

  8. PITISUTTITHUM P, Boonnak K, Chamnanchanunt S, Puthavathana P, et al
    Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.
    Lancet Infect Dis. 2017 May 19. pii: S1473-3099(17)30240.
    PubMed     Text format     Abstract available

    PLoS One

  9. NOH JY, Lim S, Song JY, Choi WS, et al
    Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season.
    PLoS One. 2017;12:e0178010.
    PubMed     Text format     Abstract available

  10. CHEN T, Huang Y, Liu R, Xie Z, et al
    Evaluating the effects of common control measures for influenza A (H1N1) outbreak at school in China: A modeling study.
    PLoS One. 2017;12:e0177672.
    PubMed     Text format     Abstract available

  11. YIN S, Kleijn D, Muskens GJDM, Fouchier RAM, et al
    No evidence that migratory geese disperse avian influenza viruses from breeding to wintering ground.
    PLoS One. 2017;12:e0177790.
    PubMed     Text format     Abstract available

  12. SELEKA M, Treurnicht FK, Tempia S, Hellferscee O, et al
    Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014.
    PLoS One. 2017;12:e0177655.
    PubMed     Text format     Abstract available


  13. LIN CY, Chia MY, Chen PL, Yeh CT, et al
    Assessment of pathogenicity and antigenicity of American lineage influenza H5N2 viruses in Taiwan.
    Virology. 2017;508:159-163.
    PubMed     Text format     Abstract available

  14. HILLYER P, Mane VP, Chen A, Dos Santos MB, et al
    Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.
    Virology. 2017;504:63-72.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.